EMed Raises $200 Million In Series A Round Led By Tom Brady And Jeff Aronin

Miami-based telehealth startup eMed has raised $200 million in a Series A round, valuing the company at over $2 billion. The funding aims to expand its AI-driven GLP-1 weight-loss platform. This investment round was led by CEO Linda Yaccarino, with participation from notable investors like NFL legend Tom Brady and Jeff Aronin, founder and CEO of Paragon Biosciences.

Summary of transaction details:

• Deal Type: Series A
• Transaction Amount: $200,000,000
• Valuation: $2,000,000,000
• Headquarters: Miami, Florida
• Key Executives: Patrice Harris, Linda Yaccarino, Jeff Aronin & Aon Consulting
• Notable Investors: Tom Brady

Founded in 2020 as a COVID-19 testing provider, eMed has since pivoted to focus on weight management, targeting the rapidly growing GLP-1 market. The company has partnered with CVS Caremark and employer Aon to deliver its program, which has shown strong adoption and retention among participants as part of its structured clinical support strategy.